Literature DB >> 7350438

Diabetes due to secretion of an abnormal insulin.

B D Given, M E Mako, H S Tager, D Baldwin, J Markese, A H Rubenstein, J Olefsky, M Kobayashi, O Kolterman, R Poucher.   

Abstract

A 51-year-old, nonobese man with diabetes mellitus had marked hyperinsulinemia (70 to 120 muU per milliliter; 502 to 860 pmol per liter) and fasting hyperglycemia (140 to 170 mg per 100 ml; 7.8 to 9.4 mmol per liter). Plasma proinsulin, glucagon, growth hormone, and cortisol levels were normal; insulin antibodies and insulin-receptor antibodies were not detected. The patient showed relatively normal insulin sensitivity, and insulin receptors on circulating monocytes were within the normal range. Insulin from the patient's serum bound to IM-9 lymphocytes and rat adipocytes approximately 40 per cent as well as insulin standards. Its biologic activity on rat adipocytes averaged 15 per cent of that expected from its immunologic concentration. The impaired biologic activity of this patient's circulating insulin was probably due to a structural abnormality. Subsequent studies of the patient's insulin (fortuitously obtained from his pancreas during a laparotomy for a pancreatic cyst) have confirmed this conclusion. (N Engl J Med 302:129-135, 1980).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7350438     DOI: 10.1056/NEJM198001173020301

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  19 in total

1.  Expression of two human growth hormone genes in monkey cells infected by simian virus 40 recombinants.

Authors:  G N Pavlakis; N Hizuka; P Gorden; P Seeburg; D H Hamer
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

2.  Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution.

Authors:  S Shoelson; M Fickova; M Haneda; A Nahum; G Musso; E T Kaiser; A H Rubenstein; H Tager
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

3.  Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus.

Authors:  Carlo Colombo; Ottavia Porzio; Ming Liu; Ornella Massa; Mario Vasta; Silvana Salardi; Luciano Beccaria; Carla Monciotti; Sonia Toni; Oluf Pedersen; Torben Hansen; Luca Federici; Roberta Pesavento; Francesco Cadario; Giorgio Federici; Paolo Ghirri; Peter Arvan; Dario Iafusco; Fabrizio Barbetti
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

4.  Human insulin B24 (Phe----Ser). Secretion and metabolic clearance of the abnormal insulin in man and in a dog model.

Authors:  S E Shoelson; K S Polonsky; A Zeidler; A H Rubenstein; H S Tager
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

5.  Structurally abnormal insulin in a diabetic patient. Characterization of the mutant insulin A3 (Val----Leu) isolated from the pancreas.

Authors:  H Sakura; Y Iwamoto; Y Sakamoto; T Kuzuya; H Hirata
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

Review 6.  Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene.

Authors:  Julie Støy; Donald F Steiner; Soo-Young Park; Honggang Ye; Louis H Philipson; Graeme I Bell
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

7.  Insulin Wakayama: familial mutant insulin syndrome in Japan.

Authors:  K Nanjo; M Miyano; M Kondo; T Sanke; S Nishimura; K Miyamura; K Inouye; B D Given; S J Chan; K S Polonsky
Journal:  Diabetologia       Date:  1987-02       Impact factor: 10.122

8.  Biochemical and clinical implications of proinsulin conversion intermediates.

Authors:  B D Given; R M Cohen; S E Shoelson; B H Frank; A H Rubenstein; H S Tager
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

9.  Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). Clinical and functional characteristics of [LeuA3] insulin.

Authors:  K Nanjo; T Sanke; M Miyano; K Okai; R Sowa; M Kondo; S Nishimura; K Iwo; K Miyamura; B D Given
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

10.  Familial hyperproinsulinemia. Two cohorts secreting indistinguishable type II intermediates of proinsulin conversion.

Authors:  D C Robbins; S E Shoelson; A H Rubenstein; H S Tager
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.